Dr. Michael A. Luther Joins Transgenomic, Inc. (TBIO)'s Board Of Directors
3/19/2014 7:24:46 AM
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced the appointment of Michael A. Luther, Ph.D., to its Board of Directors. Dr. Luther will also become a member of the Board’s audit committee. His appointment became effective March 13, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by